RDWM
CRL icon

Red Door Wealth Management’s Charles River Laboratories CRL Stock Holding History

Red Door Wealth Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-37
Closed -$4K – 458
2020
Q1 		$4K Buy
+37
New +$5.55K ﹤0.01% 349

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Red Door Wealth Management's CRL Position: Q2 2020 in Review

Red Door Wealth Management sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 37 shares — an estimated $4K sold.

Red Door Wealth Management first reported a position in CRL in Q1 2020 and held it in 1 quarter. The position peaked at $4K in Q1 2020. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

  • Red Door Wealth Management reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
  • Red Door Wealth Management sold 37 Charles River Laboratories shares in Q2 2020, an estimated $4K.
  • Red Door Wealth Management first reported a position in Charles River Laboratories in Q1 2020 and held it in 1 quarter.
  • Red Door Wealth Management's Charles River Laboratories position peaked at $4K in Q1 2020.
  • 466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Red Door Wealth Management's 13F filing for Q2 2020, filed 7 Jul 2020.